EC
TNDM icon

Elequin Capital’s Tandem Diabetes Care TNDM Stock Holding History

Elequin Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01K Buy
67
+43
+179% +$751 ﹤0.01% 573
2026
Q1 		$460 Sell
24
-66
-73% -$1.43K ﹤0.01% 581
2025
Q4 		$1.98K Buy
+90
New +$1.62K ﹤0.01% 358
2025
Q3 		– Sell
-54
Closed -$1.01K – 377
2025
Q2 		$1.01K Buy
+54
New +$1.07K ﹤0.01% 340
2025
Q1 		– Sell
-6
Closed -$216 – 629
2024
Q4 		$216 Sell
6
-115
-95% -$3.89K ﹤0.01% 474
2024
Q3 		$5.13K Buy
+121
New +$5.13K ﹤0.01% 291
2024
Q2 		– Sell
-7
Closed -$248 – 349
2024
Q1 		$248 Buy
+7
New +$188 ﹤0.01% 219
2023
Q4 		– Sell
-1
Closed -$21 – 489
2023
Q3 		$21 Sell
1
-16
-94% -$439 ﹤0.01% 384
2023
Q2 		$417 Buy
+17
New +$547 ﹤0.01% 500
2022
Q3 		– Sell
-9
Closed -$1K – 671
2022
Q2 		$1K Sell
9
-15
-63% -$1.23K ﹤0.01% 373
2022
Q1 		$3K Buy
24
+7
+41% +$817 ﹤0.01% 246
2021
Q4 		$3K Buy
+17
New +$2.29K ﹤0.01% 24

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Elequin Capital's TNDM Position: Q2 2026 in Review

Elequin Capital increased its Tandem Diabetes Care (TNDM) stake by 179% in Q2 2026, buying an estimated $751 and bringing the position to 67 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

Elequin Capital first reported a position in TNDM in Q4 2021 and has held it in 12 quarters since. The position peaked at $5.13K in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Elequin Capital held 67 shares of Tandem Diabetes Care worth $1.01K as of Q2 2026.
  • Elequin Capital bought 43 Tandem Diabetes Care shares in Q2 2026, an estimated $751.
  • Tandem Diabetes Care made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #573 holding.
  • Elequin Capital first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 12 quarters since.
  • Elequin Capital's Tandem Diabetes Care position peaked at $5.13K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.